Tianda Pharmaceuticals Limited (HKG:0455)
0.0930
+0.0070 (8.14%)
Jun 1, 2026, 1:20 PM HKT
Tianda Pharmaceuticals Market Cap
Tianda Pharmaceuticals has a market cap or net worth of 199.95 million as of June 1, 2026. Its market cap has decreased by -38.00% in one year.
Market Cap
199.95M
Enterprise Value
260.92M
Revenue
322.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since October 27, 1993, Tianda Pharmaceuticals's market cap has decreased from 315.36M to 199.95M, a decrease of -36.60%. That is a compound annual growth rate of -1.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 184.90M | -33.33% |
| Dec 31, 2025 | 277.36M | -23.67% |
| Dec 31, 2024 | 363.36M | -22.48% |
| Dec 29, 2023 | 468.71M | -46.17% |
| Dec 30, 2022 | 870.77M | 26.56% |
| Dec 31, 2021 | 688.01M | 131.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 639.06M |
| Lee's Pharmaceutical Holdings | 624.17M |
| China NT Pharma Group Company | 531.44M |
| Wai Yuen Tong Medicine Holdings | 367.75M |
| Extrawell Pharmaceutical Holdings | 237.80M |
| Shenzhen Neptunus Interlong Bio-technique Company | 189.61M |
| Regent Pacific Group | 175.09M |
| PuraPharm Corporation | 163.19M |